Akèy › Maladi fwa steatotik › Kalifòni › Fresno
Etid klinik pou Maladi fwa steatotik nan Fresno, CA
5 etid pou Maladi fwa steatotik ap chèche patisipan nan sit nan ak bò kote Fresno (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Ap rekriteFaz 3
- 89bio Clinical Study Site, Fresno
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Ap rekriteFaz 3
- 89bio Clinical Study Site, Fresno
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Ap rekriteFaz 3
- Fresno Clinical Research Center, Fresno
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
Ap rekriteFaz 3
- GSK Investigational Site, Riverdale · 22 mi lwen
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
Ap rekriteFaz 2
- GSK Investigational Site, Fresno
Etid Maladi fwa steatotik nan lòt vil
- San Antonio, TX17 etid
- New York City, NY16 etid
- Miami, FL16 etid
- San Diego, CA14 etid
- Austin, TX13 etid
- Houston, TX13 etid
- Richmond, VA12 etid
- Tucson, AZ10 etid
- Chandler, AZ10 etid
- St. Louis, MO9 etid
- Hialeah, FL9 etid
- Dallas, TX9 etid
Lòt etid nan Fresno
- Kansè Poumon ki pa ti selil7 etid
- Kansè poumon7 etid
- Kansè nan tete6 etid
- Sindrom detres respiratwa6 etid
- Leksemi mieloïd egi5 etid
- Migrèn5 etid
- Kansè pwostat5 etid
- Kansè ovè4 etid
- Blesi poumon egi4 etid
- Kansè (tout kalite)4 etid
- Limfòm Burkitt4 etid
- Sendwòm myelodisplastik3 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.